申请人:GOSFORTH CENTRE (HOLDINGS) PTY LTD.
公开号:US10028971B2
公开(公告)日:2018-07-24
Methods of treating psychiatric disorders are provided which include administration of one or more anti-epileptic agents and, optionally, one or more a psychostimulants. Also provided are pharmaceutical compositions comprising, in combination, one or more anti-epileptic agents and one or more psychostimulants. Psychiatric disorders include those associated with impaired cognitive processing, degenerative disorders such as Mild Cognitive Impairment, Parkinson's disease, dementia, non-compliance with therapeutic regimes and eating disorders, although without limitation thereto.
提供了治疗精神障碍的方法,其中包括服用一种或多种抗癫痫剂,以及可选的一种或多种精神兴奋剂。此外,还提供了由一种或多种抗癫痫剂和一种或多种精神兴奋剂组合而成的药物组合物。精神障碍包括与认知处理受损、退化性障碍(如轻度认知障碍)、帕金森病、痴呆症、不遵从治疗方案和饮食失调有关的疾病,但并不限于此。